Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.

Lu J, Kurejova M, Wirotanseng LN, Linker RA, Kuner R, Tappe-Theodor A.

J Neuroinflammation. 2012 Oct 6;9:233. doi: 10.1186/1742-2094-9-233.

2.

Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).

Olechowski CJ, Tenorio G, Sauve Y, Kerr BJ.

Exp Neurol. 2013 Mar;241:113-21. doi: 10.1016/j.expneurol.2012.12.012. Epub 2013 Jan 2.

PMID:
23291347
3.

Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.

Potter LE, Paylor JW, Suh JS, Tenorio G, Caliaperumal J, Colbourne F, Baker G, Winship I, Kerr BJ.

J Neuroinflammation. 2016 Jun 10;13(1):142. doi: 10.1186/s12974-016-0609-4.

4.

Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).

Olechowski CJ, Truong JJ, Kerr BJ.

Pain. 2009 Jan;141(1-2):156-64. doi: 10.1016/j.pain.2008.11.002. Epub 2008 Dec 11.

PMID:
19084337
5.

Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.

Khan N, Woodruff TM, Smith MT.

Pharmacol Biochem Behav. 2014 Nov;126:13-27. doi: 10.1016/j.pbb.2014.09.003. Epub 2014 Sep 16.

PMID:
25223977
6.

Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.

Zarruk JG, Berard JL, Passos dos Santos R, Kroner A, Lee J, Arosio P, David S.

Neurobiol Dis. 2015 Sep;81:93-107. doi: 10.1016/j.nbd.2015.02.001. Epub 2015 Feb 25.

PMID:
25724358
7.

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.

Abad C, Jayaram B, Becquet L, Wang Y, O'Dorisio MS, Waschek JA, Tan YV.

J Neuroinflammation. 2016 Jun 29;13(1):169. doi: 10.1186/s12974-016-0626-3. Erratum in: J Neuroinflammation. 2017 Aug 4;14 (1):157.

8.

Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.

Fiander MD, Stifani N, Nichols M, Akay T, Robertson GS.

Behav Brain Res. 2017 Jan 15;317:95-108. doi: 10.1016/j.bbr.2016.09.034. Epub 2016 Sep 14.

PMID:
27639322
9.

The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).

Benson CA, Wong G, Tenorio G, Baker GB, Kerr BJ.

Behav Brain Res. 2013 Sep 1;252:302-11. doi: 10.1016/j.bbr.2013.06.019. Epub 2013 Jun 15.

PMID:
23777648
10.

Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.

Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D.

J Neuroinflammation. 2016 Aug 26;13(1):207. doi: 10.1186/s12974-016-0686-4.

11.

Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.

Pryor WM, Freeman KG, Larson RD, Edwards GL, White LJ.

J Neurosci Res. 2015 May;93(5):697-706. doi: 10.1002/jnr.23528. Epub 2014 Dec 15.

PMID:
25510644
12.

Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE).

Benson C, Paylor JW, Tenorio G, Winship I, Baker G, Kerr BJ.

Exp Neurol. 2015 Sep;271:279-90. doi: 10.1016/j.expneurol.2015.05.017. Epub 2015 May 29.

PMID:
26033473
13.

Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.

Theotokis P, Touloumi O, Lagoudaki R, Nousiopoulou E, Kesidou E, Siafis S, Tselios T, Lourbopoulos A, Karacostas D, Grigoriadis N, Simeonidou C.

J Neuroinflammation. 2016 Oct 11;13(1):265.

14.

Voluntary wheel running differentially affects disease outcomes in male and female mice with experimental autoimmune encephalomyelitis.

Mifflin KA, Frieser E, Benson C, Baker G, Kerr BJ.

J Neuroimmunol. 2017 Apr 15;305:135-144. doi: 10.1016/j.jneuroim.2017.02.005. Epub 2017 Feb 11.

PMID:
28284334
15.

2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms.

Li F, Zhang ZX, Liu YF, Xu HQ, Hou ST, Zheng RY.

Brain Res. 2012 Nov 5;1483:13-9. doi: 10.1016/j.brainres.2012.09.016. Epub 2012 Sep 14.

PMID:
22985669
16.

Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.

Berghmans N, Heremans H, Li S, Martens E, Matthys P, Sorokin L, Van Damme J, Opdenakker G.

J Neuroinflammation. 2012 Oct 25;9:243. doi: 10.1186/1742-2094-9-243.

17.
18.

Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.

Hidaka Y, Inaba Y, Matsuda K, Itoh M, Kaneyama T, Nakazawa Y, Koh CS, Ichikawa M.

J Neurol Sci. 2014 May 15;340(1-2):117-22. doi: 10.1016/j.jns.2014.02.039. Epub 2014 Mar 11.

PMID:
24655735
19.

Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.

Frezel N, Sohet F, Daneman R, Basbaum AI, Braz JM.

Exp Neurol. 2016 Sep;283(Pt A):224-34. doi: 10.1016/j.expneurol.2016.06.019. Epub 2016 Jun 23.

20.

Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.

Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O.

J Neuroinflammation. 2016 Feb 26;13:48. doi: 10.1186/s12974-016-0512-z.

Supplemental Content

Support Center